The Middle East and Africa Clinical Trials Market has been estimated at USD 1.18 Billion in 2016 and is projected to reach USD 1.70 Billion by 2021, at a CAGR of 7.55% during the forecast period from 2016 to 2021
Clinical trials are conducted to collect data regarding the safety and efficacy of new drug and device development. Trials can be quite costly, depending on a number of factors. The sponsor may be a governmental organization or a pharmaceutical, biotechnology or medical device company. Certain functions necessary to the trial, such as monitoring and lab work, may be managed by an outsourced partner, such as a contract research organization or a central laboratory.
The market for Clinical Trials is mainly driven due to alliances between the pharma-biotech companies and the clinical research organizations, increasing demand for outsourcing clinical development and increasing demand of innovative solutions in healthcare industry. But, the market growth can be hampered due to emerging shortage of clinical resources such as lack of disease population, well trained labor, and sound medical infrastructure are delaying the process to initiate trials.
Download free sample report: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-clinical-trials-market-1657/request-sample
Middle East and Africa market for Clinical Trials is segmented based on Phase, design and indication. By Phase, the market is further sub-segmented into Phase I, Phase II, Phase III. By design, the market is further sub-segmented into Interventional trials, Observational trials, Expanded Access trials. By indication, the market is further sub-segmented into Autoimmune, Blood disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental disorders, Metabolic, Musculoskeletal, Nose, Ophthalmology. Cancer and CNS are the largest market share contributors to the market. Segments like Gastrointestinal, Circulatory, Dermatology and Mental Disorders are moving with high CAGR due to their increasing occurrence.
Geographically, Middle East and Africa market for Clinical Trials is segmented into Middle East region and Africa region. The Clinical Trials market in the Middle East and Africa region is projected to grow at the high CAGR. Emerging countries account for the largest share due to support from the respective government bodies and growing trend of rising strategic alliances, joint ventures and acquisitions.
- Phase I
- Phase II
- Phase III
- Y-o-Y Growth Analysis, By Phases
- Market Attractiveness Analysis, By Phases
- Market Share Analysis, By Phases
- Interventional trials
- Observational trials
- Expanded Access trials
- Y-o-Y Growth Analysis, By Design
- Market Attractiveness Analysis, By Design
- Market Share Analysis, By Design
- Blood disorders
- Mental disorders
- Y-o-Y Growth Analysis, By Indications
- Market Attractiveness Analysis, By Indications
- Market Share Analysis, By Indications
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Team Lead (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases